Immune Classification Tool for Determining Survival Outcomes in Cancer
卷宗概要
申请人
London Health Sciences Centre Research Inc.; The Regents of the University of California
发明人
Yu Fan Zeng; Anthony Nichols; John Barrett; Paul Boutros; Joseph Mymryk
IPC 分类
CPC 分类
An immune classification tool useful for determining survival outcomes in cancer patients based on the abundance in gene expression of CD3E, ZAP70 and IRF4 in a cancer tissue sample. The immune classification tool is able to stratify cancer patients, including HPV+HNSCC, HPV−HNSCC and cervical cancer patients, into the three immune groups (immune rich, immune desert, and mixed) that are strongly associated with disease-free survival.
原文（中文）
An immune classification tool useful for determining survival outcomes in cancer patients based on the abundance in gene expression of CD3E, ZAP70 and IRF4 in a cancer tissue sample. The immune classification tool is able to stratify cancer patients, including HPV+HNSCC, HPV−HNSCC and cervical cancer patients, into the three immune groups (immune rich, immune desert, and mixed) that are strongly associated with disease-free survival.